Editor's Note Patients with severe cases of tricuspid regurgitation (in which a critical heart valve fails to close properly) now have a new treatment option thanks to the recent US Food and Drug Administration (FDA) approval of the ENVOQUE tricuspid valve replacement system, according to a February 2 press release…

Read More

Editor's Note:  Surgeons successfully tested three fixes for a leaky heart valve on a biological pig heart fitted with a silicone robotic pump, HealthDay reported on January 11. According to the article, the biorobotic heart offers significant advantages over existing heart simulators. These include a longer shelf life, greater ability…

Read More

Editor's Note Researchers are studying how heart muscle cells called cardiomyocytes can be repaired and regenerated to improve functioning and help prevent more serious long-term consequences. The study, titled “Reduced mitochondrial protein translation promotes cardiomyocyte proliferation and heart regeneration,” was published by the journal Circulation—part of the American Heart Association—on…

Read More

Editor's Note For the first time, researchers have designed a calculator that estimates a person’s risk for developing cardiovascular disease (CVD) over the next 30 years. The news was announced in a statement from the American Heart Association in the journal Circulation on November 10. 1 in 3 U.S. adults…

Read More

Editor's Note This study by researchers at Cedars-Sinai Medical Center, Los Angeles, finds that redo transcatheter aortic valve replacement (TAVR) procedures are both safe and effective. Of 350,591 patients in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry who underwent TAVR with balloon-expandable valves between November…

Read More

Editor's Note The Food and Drug Administration (FDA), on August 31, identified the recall by Getinge/Maquet/Datasocpe of its Cardiosave Hybrid and Rescue Intra-aortic Balloon Pumps (IABPs) as Class I, the most serious. The FDA posted four recalls for four separate reasons: Because they may overheat when the device’s internal temperature…

Read More

Editor's Note The Essenz™ In-Line Blood Monitor (ILBM) has received U.S. FDA 510(k) clearance and CE mark, as announced by manufacturer LivaNova on August 30. The new ILBM provides “accurate and continuous measurement of essential blood parameters for perfusionists throughout cardiopulmonary bypass procedures,” and integrates with the company’s Essenz Perfusion…

Read More

Editor's Note The Food and Drug Administration (FDA), on August 17, identified the recall by Abiomed of the labeling for its Impella RP Flex with Smart Assist System Catheter as Class I, the most serious. The recall was initiated because the catheters’ instructions for use did not appropriately address precautions…

Read More

Editor's Note This study from the UK finds that patients are not given sufficient information about innovative surgical procedures and their potential risks and uncertainties. Researchers collected data on seven cases, using preoperative interviews with surgeons, audio-recorded consultations during which innovative procedures were discussed between surgeons and patients, and postoperative…

Read More

Editor's Note This study from the Ohio State University Wexner Medical Center, Columbus, examines the association between long-standing poverty and postoperative outcomes. The analysis included 335, 595 patients who underwent lung resection, colectomy, coronary artery bypass grafting, or lower extremity joint replacement, and who were categorized according to the duration…

Read More